Navigation Links
Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV
Date:12/1/2009

Recent Reviews In Major Peer Review Journals Have Identified The PADDS As One Of The Most Promising New Developments For The Evidence-Based Assessment Of Attention And Executive Functioning Difficulties. Some Of The Most Recent Are Listed Below.

(PRWEB) December 1, 2009 -- Review written by: Leesa V. Huang Ph.D. for the Journal of Attention Disorders, Volume 13, No. 3 November 2009. A nice synopsis of this article is available on PubMed Here

Review written by: Steven Spector, Ph.D., Eric A. Youngstrom, Ph.D., Kristin D. Anderson, Psy.D. for The ADHD Report Volume 17 Number 5, October 2009

An Expert Interview with Dr. Thomas Pedigo on Evidence-Based Assessment by Laurie Barclay, MD for MedScape Today from WebMD

An in depth review from Buros Institute of Mental Measurments is scheduled to be released electronically in Test Reviews Online January of 2010 and will be included in theBuros' 18th Mental Measurments Yearbook in Spring 2010.

The Pediatric Attention Disorders Diagnostic Screener, or PADDS, is a powerful new evidence-based Attention Deficit Hyperactivity Disorder (ADHD) assessment software program used for testing attention and executive function disorders in children ages 6 through 12. Consisting of the Computer Administered Diagnostic Interview (CADI), the Swanson, Nolan, and Pelham—IV (SNAP-IV) Parent rating scale and Teacher rating scale, and three computer administered objective measures called the Target Tests of Executive Functioning (TTEF). The actuarial / statistical reporting functions make available an automatically calculated predictive index for scoring and reporting. This method uses Bayesian probability to calculate diagnostic likelihood ratios, which are then graphed on a Nomogram to provide incremental validity when combining results from multiple measures so that each unique data source can be allowed to contribute to (or detract from, as the case may be) the prediction (Cumulative probability) of the diagnosis. The results are also given in a more traditional, normalized, relative Standard score, T-score, Z-Score, and Percentile rank format for comparison to the non-clinical reference group.

We are currently engaging in a nationwide normative effort for our newly developed set of measures of Executive Functioning TTEF-OV. These measures referred to as the Target Tests of Executive Functioning-OV (Older Version) represent the upward extension of the child version of these measures published by TTI. These measures are designed to help gain greater insight for an overall assessment of attention and working memory in Adolescents and Adults. TTI expects to have this research completed and published in the spring of 2010, as well as a completed, release version of the TTEF-OV software, with new Auditory Measures for both versions expected soon after.

PADDS and TTEF-OV are designed for use by Pediatricians, Psychiatrists, Psychologists, and other qualified mental health professionals. They are available directly from Targeted Testing Inc and other major psychological test publishers.

Targeted Testing Inc., founded by Dr. Thomas K. Pedigo Ed.D. and Kenneth L. Pedigo, is currently developing and researching several new lines of computer administered and evidence-based assessments systems to be used in screening psychological disorders. Their primary developmental approach consists of two main areas of focus. The first relates to integrating an updated construct of the disorders and the specific criteria, while the second addresses the question of how to enhance diagnostic accuracy in an efficient manner.

Targeted Testing Inc. is a member of the Association of Test Publishers.

For more information about the PADDS or TTEF-OV, please contact Kenneth Pedigo by calling 1-877-425-1093, or visit our website www.targettest.com

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3270314.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study suggests brain tumors need treatment with multiple targeted drugs
2. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
3. Research suggests targeted treatment strategies for lupus
4. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
6. Gleevec, the targeted cancer pill, delivers more good news to patients
7. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
8. Light powered platinum more targeted and 80 times more powerful than similar cancer treatments
9. A major step toward a more targeted treatment for auto-immune diseases?
10. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
11. New study of targeted therapies for breast cancer -- model for global clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Targeted Testing Receives Favorable Reviews On  PADDS,  Begins  Nationwide Research Study On The Target Tests of Executive Functioning-OV
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: